Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Amphastar/WPI Generic Enox TRO Extended, Injunction Ruling Delayed
Tweet
Share
E-mailGet Alerts MNTA Hot Sheet
Price: $52.48 --0%
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Momenta Pharmaceuticals (NASDAQ: MNTA) price target of $15.00.
Canaccord analyst, Ritu Baral, said, "Reiterate rating and price target on generic Copaxone potential, biosimilars. We think m-enox sales revenue to Momenta will decline rapidly Q4/11 on Amphastar’s enox and authorized generic launch. We still think the recently completed Teva (Nasdaq: TEVA) generic Copaxone infringement trial will result in Momenta/Sandoz’s favor (we think mid-2012) and Momenta will become a biosimilars development leader."
For more ratings news on Momenta Pharmaceuticals click here and for the rating history of Momenta Pharmaceuticals click here.
Shares of Momenta Pharmaceuticals closed at $13.34 yesterday.
Canaccord analyst, Ritu Baral, said, "Reiterate rating and price target on generic Copaxone potential, biosimilars. We think m-enox sales revenue to Momenta will decline rapidly Q4/11 on Amphastar’s enox and authorized generic launch. We still think the recently completed Teva (Nasdaq: TEVA) generic Copaxone infringement trial will result in Momenta/Sandoz’s favor (we think mid-2012) and Momenta will become a biosimilars development leader."
For more ratings news on Momenta Pharmaceuticals click here and for the rating history of Momenta Pharmaceuticals click here.
Shares of Momenta Pharmaceuticals closed at $13.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lowe's (LOW) PT Lowered to $275 at Guggenheim
- Wells Fargo Upgrades Portland General Electric Company (POR) to Overweight
- William Blair Starts Beta Bionics, Inc. (BBNX) at Market Perform
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
